Banner

BiomarkersofmyocardialinjuryinLupusnephritis

• 2020
Back
Publication Information
Authors MohamedE.T.ibrahim,ElmetwallyLotfyElshahawy,AshrafTalaat Mahmoud,RehabSalahNasr,AhmedEMansour
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type Local
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Background
Cardiovasculardisease(CVD)isthemaincauseofdeathinsystemiclupus
erythematosus(SLE)andlupusnephritis(LN)patients.Thisstudyaimedto
evaluatetheprevalenceofmyocardialinjuryamongSLEpatientswithout
nephritisandLNpatients,determinewhetherserum high-sensitivitycardiac
troponinT(HS-cTnT)andcreatinephosphokinase-MB(CKMB)mighthelpto
identifyLN patientsatriskforCVD andidentifyLN asariskfactorfor
myocardialinjury.
Methods:
Thisstudywasconductedon50patients(30LNpatientsand20SLEpatients
withoutnephritis).TheSLEdiseaseactivityindex(SLEDAI)andSystemic
Lupus InternationalCollaborating Clinics Damage Index (SLICC/DI)were
assessed.Laboratoryinvestigations,cardiacenzymes(Hs-TnTandCKMB),
andtransthoracicechocardiographywereperformed.
Results:
OurresultsdemonstratedahigherprevalenceofCVDinLNpatients.28LN
(93.3%)versus10SLE(50%)patientshaddetectablehighsensitivitytroponin
(Hs-TnT)withamean(29.77±18.22ng/L)versus(7.2±6.21ng/L)respectively,
themeanvalueofcreatinephosphokinase-MB(CKMB)washigherinLNthan
SLEpatients(23.9±18.6ug/Lversus14.8±9.4ug/Lrespectively).Multilinear